Friday, December 26

Health

Study links kidney disease to faster cognitive decline
Health

Study links kidney disease to faster cognitive decline

Chronic kidney diseases may accelerate cognitive decline but its manifestation differs in men and women, according to a new study. The decline is primarily due to damage to the "heart-brain link" triggered by chronic kidney illness, it said. Studying a rural population in the US, researchers from Marshall University found that men with chronic kidney disease experienced a higher cognitive impairment and a more pronounced reduction in heart function, compared to women. The findings, published in the American Journal of Physiology-Heart and Circulatory Physiology, suggest a stronger relation between the heart-brain link and cognitive decline among men, the researchers said. The study also sheds light on why men with chronic kidney diseases often face more severe cognitive effects, and po...
25 pct of couples undergoing infertility treatment face catastrophic expenditure
Health

25 pct of couples undergoing infertility treatment face catastrophic expenditure

The average out-of-pocket expenditure for IVF treatment is Rs 1,10,104 at public hospitals and Rs 2,37,851 at private hospitals, with 85 per cent of participants incurring catastrophic health expenditure, a new study has revealed. According to the report by the Indian Council of Medical Research - National Institute for Research in Reproductive and Child Health (ICMR-NIRRCH), the median out-of-pocket expenditure for infertility treatment at the country`s public hospitals and private hospitals is Rs 7,340 and Rs 11,834, respectively, with 25 per cent incurring catastrophic health expenditure. The health system cost of providing one IVF cycle was estimated to be Rs 81,332. The cost for subsequent IVF cycles was Rs 35,087, the report said. The total budget estimates for providing IVF servi...
Anger and the city: Doctors share expert strategies to manage road rage
Health

Anger and the city: Doctors share expert strategies to manage road rage

In fast-paced, densely populated metropolitans, the daily grind often involves navigating a complex web of environmental and digital stressors. While a fleeting moment of irritation in traffic is completely normal—"everyday frustration"—a more intense, chronic reaction is taking a significant toll on mental and physical health.  This pervasive issue, often manifesting as road rage or chronic urban stress, is more than just a bad mood; it`s a full-body stress reaction that, over time, can lead to serious health risks. This Anger Awareness Week, mental health experts delve into the clinical, physiological, environmental, and digital roots of urban rage, and offer actionable strategies to reclaim your calm. Understanding the clinical shift: From frustration to rageMehezabin Dordi, clinical ...
Docs say 50 per cent of Mumbai’s corporate employees showing stress on skin
Health

Docs say 50 per cent of Mumbai’s corporate employees showing stress on skin

As Mumbai’s corporate culture becomes more demanding, there is a rise in stress-related skin problems. The fast pace of work, long commutes, poor sleep quality, and constant screen exposure are silently damaging skin health. Stress does not just affect the mind; it directly impacts the skin by triggering inflammation, oil imbalance, and reduced skin repair. 50 per cent of employees in the city feel their skin has become dull, uneven, and more prone to acne and eczema. With a growing number of professionals aged 25–45 seeking treatment for lifestyle-related skin concerns, experts are urging people to consider skincare as an essential part of their overall health. Dr Shareefa Chause, dermatologist in Mumbai said, "Currently, corporate stress is not only impacting the employee’s mind but eve...
IIT Bombay study shows how TB bacteria shield themselves from antibiotics
Health

IIT Bombay study shows how TB bacteria shield themselves from antibiotics

The bacteria Mycobacterium tuberculosis, which causes the world’s most infectious disease Tuberculosis (TB), can survive antibiotic treatment and live longer by changing their outer fat coating, according to a new study led by researchers from the Indian Institute of Technology (IIT) Bombay on Wednesday.  Even with effective antibiotics and widespread vaccination campaigns, TB continues to take lives. Globally, 10.7 million people developed TB and 1.23 million died from the disease in 2024, while India carries one of the highest burdens -- over 2.71 million cases in 2024. In the study, published in the Chemical Science journal, the researchers showed that the key to the bacteria`s drug tolerance lies in their membranes -- complex barriers made mostly of fats, or lipids that protect the ...
Study: Malaria and Dengue cases rising fast due to climate change
Health

Study: Malaria and Dengue cases rising fast due to climate change

Mosquito-borne diseases such as malaria and dengue could be the most rapidly escalating threats to humanity, followed by tuberculosis and HIV/AIDS, with climate change emerging as a primary driver of disease escalation, according to a survey of over 3,700 health professionals and researchers from across 151 countries. Socioeconomic inequality, which can impact one`s access to healthcare, and antimicrobial resistance that can undermine treatments against wide-ranging infections may also contribute to disease escalation, said the participants, nearly 90 per cent of whom were based in low and middle-income countries. Climate change, poverty and drug resistance could be coming together to create an escalating health crisis that could become a "creeping catastrophe" if left unaddressed, findi...
Common constipation drug can help halt kidney decline: Study
Health

Common constipation drug can help halt kidney decline: Study

A surprising link between constipation and kidney decline led researchers to test lubiprostone, revealing that it can protect kidney function. The results point toward gut-based, mitochondria-boosting therapies as a promising new avenue for CKD care. Chronic kidney disease (CKD) affects people across the globe and often progresses to the point where patients rely on routine dialysis to survive. Although the condition is widespread and serious, there are still no approved medications that can actively restore kidney function. A team led by Professor Takaaki Abe at the Tohoku University Graduate School of Medicine has uncovered an unexpected approach by repurposing a constipation medication. Their work marks the first time that this drug (lubiprostone) has been shown to slow the loss of k...
Study links common childhood virus to bladder cancer
Health

Study links common childhood virus to bladder cancer

UK researchers have found a common childhood virus that can trigger DNA damage leading to bladder cancer later in life.  Tackling the virus early could open the door to preventing bladder cancer later, said the team from the University of York. The study, published in Science Advances, revealed that after being contracted in childhood, the BK virus usually lies dormant in the kidney. BK virus infections do not have obvious symptoms, but physicians have learned a lot about the virus from the experiences of kidney transplant recipients who have to take immunosuppressants to prevent the immune system from targeting their new kidney. In laboratory studies using the human tissue that lines the urinary tract (urothelium), the team observed DNA damage patterns caused by the cell`s antiviral d...
Overcoming odds, legal woes, Gujarat`s 3-feet-tall doctor gets first job
Health

Overcoming odds, legal woes, Gujarat`s 3-feet-tall doctor gets first job

Standing three feet tall and aged just 25, Gujarat resident Ganesh Baraiya has scripted an inspiring tale of grit and determination, fulfilling his childhood dream of becoming a doctor and securing his first appointment as a medical officer. The man from a farming family, detected with 72 per cent locomotor disability, fought lengthy legal battles, leading up to the Supreme Court, to become a doctor and faced several other overwhelming odds, but the thought of giving up the fight never crossed his mind. His efforts have borne fruit and Baraiya last week joined Sir Takhtasinhji General Hospital, a government facility in Bhavnagar district, as a Medical Officer (Class-2). "Since childhood, whenever I was asked about my ambition, I used to say `I want to be a doctor`," disclosed the 25-yea...
Obesity treatment: WHO guideline on the use of GLP-1 therapies
Health

Obesity treatment: WHO guideline on the use of GLP-1 therapies

The World Health Organization has released its first global guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity, recognising the condition as a chronic and relapsing disease. The move comes amid rising global demand for GLP-1 medications—such as semaglutide and liraglutide—currently used for diabetes and weight management. Here’s what the new guidance means and why it matters. What are GLP-1 therapies? GLP-1 therapies (glucagon-like peptide-1 receptor agonists) are medications that mimic the body’s natural GLP-1 hormone, which regulates blood sugar and appetite. Originally developed to manage type-2 diabetes, these drugs are now widely used for weight loss and obesity treatment. Beyond weight management, some GLP-1 medicines have shown additional benef...